Chronic hand eczema (CHE) is a persistent ... are also susceptible to developing CHE. Although multiple treatments for CHE are available, significant unmet need remains in long-term disease ...

A significant unmet need in long-term management for chronic hand eczema (CHE ... by side effects such as skin thinning. Meanwhile, treatments such as emollients and moisturisers provide hydration ...

From atopic dermatitis to contact dermatitis, discover expert-backed treatments and lifestyle changes that can help manage ...

NEW DELHI: In a significant breakthrough for those suffering from chronic hand eczema, a widespread skin condition resistant to existing treatments, a clinical study by RML Hospital has shown a ...

The following is a summary of “Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients ...

The study highlights significant implications for treatment-resistant cases ... Additionally, individuals suffering from acute hand eczema often experience considerable disruption in their ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...

Between 11% and 20% of the population has chronic hand eczema. Respondents used an average of 1.7 prescriptions. 26% used six or more over-the-counter treatments. BOSTON — Chronic hand eczema ...